Understanding and improving cellular immunotherapies against cancer: From cell-manufacturing to tumor-immune models

R Ringquist, D Ghoshal, R Jain, K Roy - Advanced Drug Delivery Reviews, 2021 - Elsevier
The tumor microenvironment (TME) is shaped by dynamic metabolic and immune
interactions between precancerous and cancerous tumor cells and stromal cells like …

[HTML][HTML] Targeting cell death signaling in colorectal cancer: current strategies and future perspectives

BC Koehler, D Jäger… - World journal of …, 2014 - ncbi.nlm.nih.gov
The evasion from controlled cell death induction has been considered as one of the
hallmarks of cancer cells. Defects in cell death signaling are a fundamental phenomenon in …

Carcinoembryonic antigen (CEA)-based cancer vaccines: recent patents and antitumor effects from experimental models to clinical trials

M Turriziani, M Fantini, M Benvenuto… - Recent patents on …, 2012 - ingentaconnect.com
Carcinoembryonic antigen (CEA), a glycosylated protein of MW 180 kDa, is overexpressed
in a wide range of human carcinomas, including colorectal, gastric, pancreatic, non-small …

[HTML][HTML] Lentiviral vector mediated claudin1 silencing inhibits epithelial to mesenchymal transition in breast cancer cells

X Zhao, Y Zou, Q Gu, G Zhao, H Gray, LM Pfeffer, J Yue - Viruses, 2015 - mdpi.com
Breast cancer has a high incidence and mortality rate worldwide. Several viral vectors
including lentiviral, adenoviral and adeno-associated viral vectors have been used in gene …

DNA and adenovirus tumor vaccine expressing truncated survivin generates specific immune responses and anti-tumor effects in a murine melanoma model

H Zhang, Y Wang, C Liu, L Zhang, Q Xia… - Cancer Immunology …, 2012 - Springer
Survivin is overexpressed in major types of cancer and is considered an ideal “universal”
tumor-associated antigen that can be targeted by immunotherapeutic vaccines. However, its …

Cancer vaccines targeting carcinoembryonic antigen: state-of-the-art and future promise

SR Gameiro, ML Jammeh, JW Hodge - Expert review of vaccines, 2013 - Taylor & Francis
Concurrent with the US FDA's approval of the first therapeutic cancer vaccine, and
supported by mounting clinical evidence indicating that targeting carcinoembryonic antigen …

Immunization with adenovirus LIGHT-engineered dendritic cells induces potent T cell responses and therapeutic immunity in HBV transgenic mice

W Jiang, R Chen, X Kong, F Long, Y Shi - Vaccine, 2014 - Elsevier
LIGHT, a TNF superfamily member (TNFSF14), is a type II transmembrane protein
expressed on activated T cells and immature dendritic cells (DCs). However, the expression …

Противоопухолевые вакцины на основе дендритных клеток: от экспериментов на животных моделях до клинических испытаний

ОВ Марков, НЛ Миронова, ВВ Власов… - Acta Naturae …, 2017 - cyberleninka.ru
Стандартные методы терапии опухолевых заболеваний обладают рядом недостатков,
главные из которых неспецифичность и тяжелые побочные эффекты. Кроме того …

Antitumor vaccines based on dendritic cells: from experiments using animal tumor models to clinical trials

OV Markov, NL Mironova, VV Vlassov - Acta Naturae …, 2017 - cyberleninka.ru
The routine methods used to treat oncological diseases have a number of drawbacks,
including non-specific action and severe side effects for patients. Furthermore, tumor …

[HTML][HTML] Combination of intensive chemotherapy and anticancer vaccines in the treatment of human malignancies: the hematological experience

K Liseth, E Ersvær, T Hervig, Ø Bruserud - BioMed Research …, 2010 - hindawi.com
In vitro studies have demonstrated that cancer-specific T cell cytotoxicity can be induced
both ex vivo and in vivo, but this therapeutic strategy should probably be used as an …